Cookson Peirce & CO Inc Amgen Inc Transaction History

Cookson Peirce & CO Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$224.46 - $253.15 $27,608 - $31,137	123 Added 12.56%	1,102 $248,000
Q2 2022 Jul 20, 2022	BUY	$230.71 - $256.74 $225,865 - $251,348	979 New	979 $238,000
Q4 2020 Feb 10, 2021	SELL	$216.38 - $257.67 $345,126 - $410,983	-1,595 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$234.65 - $260.95 $97,849 - $108,816	417 Added 35.4%	1,595 $405,000
Q2 2020 Aug 07, 2020	SELL	$197.81 - $242.74 $593 - $728	-3 Reduced 0.25%	1,178 $277,000
Q1 2020 May 04, 2020	BUY	$182.24 - $241.7 $18,041 - $23,928	99 Added 9.15%	1,181 $239,000
Q4 2019 Jan 27, 2020	BUY	$189.21 - $243.2 $204,725 - $263,142	1,082 New	1,082 $260,000
Q2 2019 Jul 31, 2019	SELL	$166.7 - $195.41 $5.56 Million - $6.52 Million	-33,345 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$180.87 - $203.88 $17.8 Million - $20 Million	-98,305 Reduced 74.67%	33,345 $6.34 Million
Q4 2018 Feb 07, 2019	BUY	$178.4 - $208.25 $23.2 Million - $27.1 Million	130,120 Added 8504.58%	131,650 $25.6 Million
Q3 2018 Oct 15, 2018	BUY	$185.29 - $208.89 $283,493 - $319,601	1,530 New	1,530 $0

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Cookson Peirce & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Cookson Peirce & CO Inc with notifications on news.